Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Cell Cycle
2018 Jan 01;1710:1268-1278. doi: 10.1080/15384101.2018.1475829.
Show Gene links
Show Anatomy links
MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Jiang T
,
Sui D
,
You D
,
Yao S
,
Zhang L
,
Wang Y
,
Zhao J
,
Zhang Y
.
???displayArticle.abstract???
This study was aimed to explore the effects of miR-29a-5p expression and its target gene TPX2 (target protein for Xenopus kinesin-like protein 2) on endometrial cancer (EC) devel on EC development and to assess the prognostic impacts of TPX2. Microarray-based GEO and TCGA (the Cancer Genome Atlas) EC expression data were used to identify differentially expressed miRNAs and mRNAs. The observed potential target relationship between miR-29a-5p and TPX2 was verified using TargetScan and luciferase reporter assays. The mRNA and protein expression levels of miR-29a-5p and TPX2 were confirmed by qRT-PCR and western blot, respectively. Associations between TPX2 expression and patient prognosis were assessed using Kaplan-Meier and log-rank assays. Changes in EC-derived cell proliferation, invasion and apoptosis after exogenous miR-29a-5p and TPX2 over-expression and/or silencing were assessed using CCK-8 (cell counting kit-8), colony formation, Transwell and flow cytometry assays, respectively. We found that in primary EC tissues the expression of miR-29a-5p was down-regulated and the expression of TPX2 was up-regulated. We also found that low expression of TPX2 were associated with a better prognosis, and vice versa. Subsequent exogenous miR-29a-5p over-expression and TPX2 silencing could inhibit EC-derived cell proliferation and invasion, and to induce apoptosis. We also found that miR-29a-5p might target and repress TPX2, thereby inhibiting EC-derived cell proliferation and invasion and enhancing apoptosis. We conclude that miR-29a-5p could inhibit the proliferation and invasion of EC-derived cells and enhance the apoptosis of EC-derived cells via TPX2 down-regulation. A high TPX2 expression in primary EC tissues was found to be associated with a poor prognosis. As such, these biomarkers may serve as promising prognostic indicators.
ABBREVIATIONS: EC: Endometrial cancer; 3'-UTR: 3'-untranslated regions; TPX2: target protein for Xenopus kinesin-like protein 2; TCGA: the Cancer Genome Atlas; UCEC: uterine corpus endometrial carcinoma; CCK-8: cell counting kit-8; OD: optical density; FCM: flow cytometry; EMT: epithelial-mesenchymal transition.
Chen,
MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
2017, Pubmed
Chen,
MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
2017,
Pubmed
Geiger,
Functional analysis of prognostic gene expression network genes in metastatic breast cancer models.
2014,
Pubmed
Gu,
Identification of prognostic genes in kidney renal clear cell carcinoma by RNA‑seq data analysis.
2017,
Pubmed
Habata,
BAG3 increases the invasiveness of uterine corpus carcinoma cells by suppressing miR-29b and enhancing MMP2 expression.
2015,
Pubmed
Huang,
TPX2 is a prognostic marker and contributes to growth and metastasis of human hepatocellular carcinoma.
2014,
Pubmed
,
Xenbase
Krol,
The widespread regulation of microRNA biogenesis, function and decay.
2010,
Pubmed
Lagos-Quintana,
Identification of novel genes coding for small expressed RNAs.
2001,
Pubmed
Li,
Identification of Biomarkers Correlated with the TNM Staging and Overall Survival of Patients with Bladder Cancer.
2017,
Pubmed
Li,
Network-based approach identified cell cycle genes as predictor of overall survival in lung adenocarcinoma patients.
2013,
Pubmed
Liang,
Overexpressed targeting protein for Xklp2 (TPX2) serves as a promising prognostic marker and therapeutic target for gastric cancer.
2016,
Pubmed
,
Xenbase
Liang,
TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT.
2015,
Pubmed
Liang,
[Expression of TPX2 in hepatocellular carcinoma and its clinical significance].
2015,
Pubmed
Lujambio,
The microcosmos of cancer.
2012,
Pubmed
Markopoulos,
A step-by-step microRNA guide to cancer development and metastasis.
2017,
Pubmed
Miyamoto,
Laser-captured microdissection-microarray analysis of the genes involved in endometrial carcinogenesis: stepwise up-regulation of lipocalin2 expression in normal and neoplastic endometria and its functional relevance.
2011,
Pubmed
Montagnana,
Aberrant MicroRNA Expression in Patients With Endometrial Cancer.
2017,
Pubmed
Morice,
Endometrial cancer.
2016,
Pubmed
Neumayer,
TPX2: of spindle assembly, DNA damage response, and cancer.
2014,
Pubmed
Pérez de Castro,
Mitotic Stress and Chromosomal Instability in Cancer: The Case for TPX2.
2012,
Pubmed
Ramón,
microRNAs related to angiogenesis are dysregulated in endometrioid endometrial cancer.
2012,
Pubmed
Shi,
miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients.
2017,
Pubmed
Siegel,
Cancer Statistics, 2017.
2017,
Pubmed
Sillars-Hardebol,
TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
2012,
Pubmed
Su,
MiR-29a-3p suppresses cell proliferation in laryngocarcinoma by targeting prominin 1.
2017,
Pubmed
Tomii,
TPX2 expression is associated with poor survival in gastric cancer.
2017,
Pubmed
,
Xenbase
Wang,
[miR-491 inhibits the proliferation, invasion and migration of hepatocellular carcinoma cell via down-regulating TPX2 expression].
2016,
Pubmed
Wittmann,
Localization of the kinesin-like protein Xklp2 to spindle poles requires a leucine zipper, a microtubule-associated protein, and dynein.
1998,
Pubmed
,
Xenbase
Yang,
TPX2 overexpression in medullary thyroid carcinoma mediates TT cell proliferation.
2014,
Pubmed
,
Xenbase
Yanokura,
MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications (Review).
2010,
Pubmed
Záveský,
Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study.
2015,
Pubmed
Zhang,
DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma.
2012,
Pubmed
Zhao,
Reduced miR-29a-3p expression is linked to the cell proliferation and cell migration in gastric cancer.
2015,
Pubmed